Skip to main content
. 2017 Jul 25;38(31):2392–2411. doi: 10.1093/eurheartj/ehx383

Table 5.

Major recent studies showing elevations in Troponin I to be associated with mortality post-coronary artery bypass grafting surgery

Study Type of study and surgery Number of patients Cardiac biomarker (time) Other features Major findings
Greenson et al.43 Single centre prospective study; CABG or Aortic valve replacement 100
  • cTnI

  • CK-MB

Pre-op, 24 h and 48 h, then daily until discharge or 1 week Peak cTnI > 60 ng/mL (> 120× URL) predictive of cardiac events up to 30 days post op
Holmvang et al.35 Single centre prospective study, CABG only 103
  • cTnT

  • cTnI

  • CK-MB

  • Myoglobin

Every 2 h in first 20 h, 24, 30, 36 and 48 h, 72 and 98 h
  • ECG changes unable to differentiate between patients with or without graft failure.

  • CK-MB and cTnT (but not cTnI or Myoglobin) levels were significantly higher in patients with graft failure vs. those without. Optimal discrimination values were 30 mcg/L for CK-MB (sensitivity 67%, specificity 65%) and 3 mcg/L for cTnT (sensitivity 67%, specificity 76%).

  • In multivariate analysis cTnT > 3 mcg/L was significantly associated with graft failure (sensitivity of 75% compared to 20% for clinical criteria)

Eigel et al.44 Prospective single centre study; CABG only (Excluded MI within 7 days) 540 cTnI Prior to induction of anaesthesia and at termination of CPB cTnI level > 0.495 ng/L (> 9.9× URL for assay) measured at the end of CPB was predictive of in-hospital adverse outcomes (MI/death)
Lasocki et al.45 Single centre prospective study; CABG or valve surgery (Acute MI < 7 days were excluded) 502
  • cTnI

  • ECG changes

20 h post-op
  • cTnI < 32.5× URL ∼2.5% in hospital mortality

  • cTnI ≥ 32.5× URL ∼22.5% in hospital mortality

  • cTnI > 100× URL 44% in hospital mortality

Thielmann et al.46 Single centre prospective study: CABG only 2,078 cTnI 1, 6, 12,24 h post op
  • cTnI was a more sensitive and specific marker of graft failure at a level above 21.5 ng/mL (> 43× URL ng/mL) at 12 h and 33.4 ng/mL (>66.8× URL) at 24 h, compared to myoglobin and CK/CK-MB.

  • CK-MB and EKG changes (ST-segment deviations or new Q wave) did not predict graft failure

Paparella et al.47 Prospective Single centre study; CABG only (Patients with UA/MI < 7 days included) 230 cTnI Pre-op, 1,6,12,24 and 36 h post-op, daily from day 2 to 7
  • cTnI >260× URL (13 ng/L) predicted in-hospital mortality but not 2 year mortality;

  • Peak cTnI generally observed 24 h after surgery

Onorati et al.9 Prospective single centre study; CABG only 776
  • cTnI

  • ECG changes (New Q wave or reduction in R waves > 25%) &

  • ECHO feature of MI

Pre-op and 12, 24, 48 and 72 h post-op cTnI >3.1 μg/L (> 310× URL) at 12 h predicted increased in-hospital and 12 month mortality; Additional ECG and ECHO criteria of MI predicted worst outcome
Thielmann et al.31,48
  • Prospective single centre study

  • CABG only patients undergoing re-angiography post-op

94
  • cTnI

  • CK-MB

Pre-op, 1, 6, 12, 24, 36 and 48 h post-op cTnI was the best discriminator between PMI ′in general′ and ′inherent′ release of cTnI after CABG with a cut-off value of 10.5 ng/mL (> 21× URL) and between graft-related and non-graft-related PMI with a cut-off value of 35.5 ng/mL (>71× URL). CK-MB level and ECG changes/TEE could not differentiate between those with or without graft failure.
Croal et al.49
  • Prospective

  • CABG+ valve/other cardiac surgery

1365
  • cTnI

  • ECG changes

2 and 24 h
  • cTnI at 24 h best predictor

  • ≥53× URL 2.37 OR 30-day mortality, 2.94 OR 1 yr mortality, 1.94 OR 3 yr mortality

  • ≥27× URL 1.05 OR 30-day mortality, 1.14 OR 1 yr mortality, 1.37 OR 3 yr mortality

Provenchère et al.50
  • Prospective single centre study

  • CABG and/or valve surgery

92 cTnI 20 h post op cTnI levels were not predictive of 1 year mortality in a multivariate model.
Fellahi et al.51
  • Prospective single centre study;

  • CABG only

202 cTnI Per-op and 24 h post-op
  • cTnI ≥ 13 ng/mL (≥ 21.66 x URL) did not predict in-hospital mortality, but was predictive of 2 year mortality (18% vs. 3%; OR 7.3).

  • Best cut off to predict death ranged from 12.1 to 13.4 ng/mL (20.16–21.66× URL)

Adabag et al.34
  • Retrospective analysis

  • CABG and/or valve surgery

1186
  • cTnI

  • CK-MB

Ever 8 h for 24 h post-op, longer if no peak in 24 h cTnI level independently associated with operative (30 day) mortality; CK-MB had a weaker association with operative mortality
Muehlschlegel et al.26
  • Prospective single centre study

  • CABG only surgery

1013 cTnI Daily from day 1 to 5
  • 24 h cTnI rise ≥ 138× URL HR 2.8 for 5 yr mortality

  • cTnT at 24 h were independent predictors of 5 year mortality in a multivariate model (No additional benefit of measuring cTn beyond 24 h).

  • ECG changes alone did not predict 5 year mortality.

Petaja et al.41
  • Meta-analysis

  • CABG and/or Cardiac surgery

2348–3271 cTnI Up to 7 days post op
  • Short-term mortality (<6 mths) 8.1% ≥ 21× URL vs. 1.5% <21× URL

  • Long-term mortality (6–36 mths): 10.6% vs. 3.1% (RR 1.06–11.00%)

Hashemzadeh et al.52
  • Prospective single centre study

  • CABG +/- Valve surgery (Excluded MI within 7 days)

320 cTnI Immediately and 20 h post-op 20 h post-op cTnI had better prognostic value than immediate post-op levels. 20 h cTnI level was an independent predictor of in-hospital mortality above a value of 14 ng/mL (>10× URL)
Van Geene et al.53 Registry retrospective analysis;CABG and/or valve surgery 938 (Separate validation subset, n = 579) cTnI 1 h post-op 1 h post-op cTn values correlated with hospital mortality with the best cut-off value of 4.25 μ/L (Type of assay and URL for assay not known)
Domanski et al.29
  • Meta-analysis

  • CABG only

18,908 cTnI <24 h post op
  • 5 to < 10× URL 1.00 RR of 30 d mortality

  • 10 to < 20× URL 1.89 RR of 30 d mortality

  • 20 to < 40× URL 2.22 RR of 30 d mortality

  • 40 to < 100× URL 3.61 RR of 30 d mortality

  • ≥100× URL 10.91 RR of 30 d mortality

Ranasinghe et al.27 Retrospective analysis of 2 prospective randomized controlled clinical trials 440 cTnI 6, 12, 24, 48, 72 h post-op
  • cTnI levels at 12, 24, 48 and 72 h were all independent predictors of mortality HR ranging from 1.02 to 1.10 for these time points (>4.8 yr follow-up period).

  • Cumulative area under to curve for cTn release up to 72 h was the best predictor of mortality in this model (HR 1.45). Peak cTnI of > 13 ng/mL (URL not defined) did not predict mid-term mortality.

AUC, area under the curve; CABG, coronary artery bypass grafting; CMR, cardiac MRI; CK-MB, creatine kinase-MB fraction; d, day; ECG, electrocardiogram; ECHO, echocardiocardiogram; HR, hazards ratio; h, hour; LGE, late gadolinium enhancement; LV, left ventricle; MACE, major adverse cardiac events; MI, myocardial infarction; mth, month; ng, nanogram; ONBEAT, on-pump beating heart; CABG ONSTOP, on-pump CABG; OR, odds ratio; post-op, post-operative; PMI, perioperative myocardial injury; RR, relative risk; TEE, transoesophageal echocardiogram; cTnI, Troponin I; cTnT, Troponin T; UA, unstable angina; URL, upper reference limit; yr, year.